EE04782B1 - Interleukiin-1ß konverteeriva ensüümiga seonduv peptiid, selle kasutamine ja farmatseutiline kompositsioon - Google Patents

Interleukiin-1ß konverteeriva ensüümiga seonduv peptiid, selle kasutamine ja farmatseutiline kompositsioon

Info

Publication number
EE04782B1
EE04782B1 EEP199900178A EE9900178A EE04782B1 EE 04782 B1 EE04782 B1 EE 04782B1 EE P199900178 A EEP199900178 A EE P199900178A EE 9900178 A EE9900178 A EE 9900178A EE 04782 B1 EE04782 B1 EE 04782B1
Authority
EE
Estonia
Prior art keywords
interleukin
pharmaceutical composition
converting enzyme
enzyme peptide
peptide
Prior art date
Application number
EEP199900178A
Other languages
English (en)
Estonian (et)
Other versions
EE9900178A (et
Inventor
Muzio Marta
Introna Martino
Mantovani Alberto
Original Assignee
Applied Research Systems Ars Holding N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems Ars Holding N.V. filed Critical Applied Research Systems Ars Holding N.V.
Publication of EE9900178A publication Critical patent/EE9900178A/xx
Publication of EE04782B1 publication Critical patent/EE04782B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EEP199900178A 1996-10-31 1996-10-31 Interleukiin-1ß konverteeriva ensüümiga seonduv peptiid, selle kasutamine ja farmatseutiline kompositsioon EE04782B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1996/004738 WO1998018823A1 (en) 1996-10-31 1996-10-31 Ice inhibiting peptides

Publications (2)

Publication Number Publication Date
EE9900178A EE9900178A (et) 1999-12-15
EE04782B1 true EE04782B1 (et) 2007-02-15

Family

ID=8166387

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900178A EE04782B1 (et) 1996-10-31 1996-10-31 Interleukiin-1ß konverteeriva ensüümiga seonduv peptiid, selle kasutamine ja farmatseutiline kompositsioon

Country Status (20)

Country Link
US (1) US6380162B1 (de)
EP (1) EP0938500B1 (de)
JP (1) JP4018154B2 (de)
KR (1) KR100502211B1 (de)
AR (1) AR011269A1 (de)
AT (1) ATE277079T1 (de)
BR (1) BR9612755A (de)
CA (1) CA2269638C (de)
DE (1) DE69633463T2 (de)
DK (1) DK0938500T3 (de)
EA (1) EA001866B1 (de)
EE (1) EE04782B1 (de)
ES (1) ES2225893T3 (de)
IL (1) IL129669A0 (de)
NO (1) NO323517B1 (de)
PT (1) PT938500E (de)
SI (1) SI0938500T1 (de)
UA (1) UA70291C2 (de)
WO (1) WO1998018823A1 (de)
ZA (1) ZA979712B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2335232T3 (es) * 2005-06-21 2010-03-23 Xoma Technology Ltd. Anticuerpos y fragmentos de los mismos que se unen a la il-1 beta.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1270662B (it) * 1994-10-13 1997-05-07 Applied Research Systems Antagonista della interleuchina-1
US5981713A (en) * 1994-10-13 1999-11-09 Applied Research Systems Ars Holding N.V. Antibodies to intereleukin-1 antagonists

Also Published As

Publication number Publication date
PT938500E (pt) 2005-02-28
CA2269638C (en) 2005-01-18
UA70291C2 (en) 2004-10-15
ES2225893T3 (es) 2005-03-16
KR100502211B1 (ko) 2005-07-19
US6380162B1 (en) 2002-04-30
KR20000052858A (ko) 2000-08-25
CA2269638A1 (en) 1998-05-07
WO1998018823A8 (en) 1999-06-17
DE69633463D1 (de) 2004-10-28
ZA979712B (en) 1999-02-05
BR9612755A (pt) 1999-10-19
DE69633463T2 (de) 2006-02-23
IL129669A0 (en) 2000-02-29
DK0938500T3 (da) 2005-01-17
SI0938500T1 (en) 2005-02-28
EP0938500B1 (de) 2004-09-22
NO323517B1 (no) 2007-06-04
NO992079D0 (no) 1999-04-29
EE9900178A (et) 1999-12-15
EA199900432A1 (ru) 1999-10-28
AU729946B2 (en) 2001-02-15
AU2702399A (en) 1999-08-16
ATE277079T1 (de) 2004-10-15
WO1998018823A1 (en) 1998-05-07
JP2001510452A (ja) 2001-07-31
AR011269A1 (es) 2000-08-16
EA001866B1 (ru) 2001-10-22
EP0938500A1 (de) 1999-09-01
NO992079L (no) 1999-06-16
JP4018154B2 (ja) 2007-12-05

Similar Documents

Publication Publication Date Title
AU1226297A (en) Basic protein composition, basic peptide composition and application thereof
EE04144B1 (et) Farmatseutiline kompositsioon ja selle kasutamine
BR9708400A (pt) Composição sua preparação e uso
EE9800136A (et) Depooravimiks sobiv farmatseutiline kompositsioon, selle valmistamismeetod ja kasutamine
FI952119L (fi) Stabiili pakastekuivattu koostumus, joka sisältää proteiinia ja testipakkaus
ID22889A (id) Komposisi kopolimer etilena dan penggunaannya
EE04452B1 (et) Farmatseutiliselt aktiivne morfolinool ja selle kasutamine
EE03901B1 (et) Elastne vaheriie ja selle kasutamine
BR9504791B1 (pt) composto de polipeptìdeo e composição farmacêutica.
FI964311L (fi) Bifunktionaalinen proteiini, valmistus ja käyttö
EE03676B1 (et) Mullpakend, selle valmistamise meetod ja mullpakendi kasutamine
ID24520A (id) Analog-analog peptida lh-rh, penggunaannya dan komposisi farmasi yamg mengandungnya
EE04427B1 (et) Suletud mahuti ja selle kasutamine
EE200100314A (et) Meetod farmatseutilise kompositsiooni valmistamiseks, farmatseutiline kompositsioon ja selle kasutamine
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
DE69634489D1 (de) Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
EP0885293A4 (de) Menschliche chemokin-polypeptide.
EE03387B1 (et) Kombineeritud ravimpreparaat, selle kasutamine ja meetod selle valmistamiseks
FI972988L (fi) Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
BR9709406B1 (pt) fluorenonas alquiloxiamino substituìdas e composição farmacêutica contendo as mesmas.
EE04260B1 (et) Farmatseutiline kompositsioon, selle valmistamisemeetod ja kasutamine
ID18698A (id) Komposisi farmasi
EE200200096A (et) IREN-valk, selle valmistamine ja kasutamine
FI972965A0 (fi) Uusia peptidejä, niiden valmistus ja käyttö
EE9900178A (et) Interleukiin-1ß konverteeriva ensüümiga seonduv peptiid, selle kasutamine ja farmatseutiline kompositsioon

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20091031